Ideas to Action:

Independent research for global prosperity

Global Health Policy Blog

CGD experts offer ideas and analysis on global health issues and how better policies can improve well-being for everyone. Also check out our Views from the Center blog and US Development Policy blog.

Global Health Policy Blog

 

Ambassador Deborah Birx speaking at CGD. Photo by Kaveh Sardari

PEPFAR’s New Targets for Local Implementation: Commendable in Theory, Complicated in Practice

In July, United States Global AIDS Coordinator Deborah Birx made a striking commitment: under her leadership, the President’s Emergency Plan for AIDS Relief (PEPFAR) would direct at least 40 percent of its funding to host country governments or organizations by the end of 2019—rising to 70 percent by the end of 2020. The bottom line: PEPFAR’s local targets are commendable in theory, but we suspect their application in practice will prove complicated. Below is our take on the related issues—and some recommendations for PEPFAR to forge the most effective path forward.

adorable baby

Time to Deliver: New Ebola Findings Highlight the Need to Improve Evidence and Interventions for Pregnant Women

On July 23, an outbreak report in The Lancet Infectious Diseases documented the case of a female Ebola survivor who transmitted the virus to family members more than year later. This raises new questions about how pregnancy may impact the presentation of Ebola virus disease (EVD), not just for women in the near term but across multiple pregnancies, and potentially as the source of new outbreaks.

What You Should Know About Global Health Financing Transitions: Five Key Takeaways

In recent years many global health institutions—particularly Gavi and the Global Fund—have adopted eligibility and transition frameworks for the countries they support. These frameworks lay out criteria under which countries will lose eligibility for their support, and, typically, a gradual timeframe to phase out external financing. The question of how these transitions will play out in practice—and whether global health progress will be put at risk through premature or poorly planned transitions—is a hot topic in global health.

Photo of a stethoscope and a calculator

Global Health Development Value Frameworks: Are We Calculating Well and Wisely?

The last several years have seen the development of many decision-support tools (“value frameworks”) for supporting policy and investment decisions. These tools make use of lots of numbers representing factors of undoubted importance in decision making, and they synthesise this information into a decision-relevant score or ranking or choice recommendation. Sometimes it is hard to trace how the numbers are combined; in other cases, although the relevant formulae are spelled out, it is hard to see why the numbers are combined in a particular way.

Photo of a hand with a syringe and a vaccine

Global Health Security in the Trump Era: Time to Worry?

Is it time to ring the alarm bell on a declining US commitment to global health security? For most of the past year, I would have said no. But after the last few weeks, I’m starting to think so. And the simultaneous news of a new Ebola outbreak in the Democratic Republic of Congo underscores the stakes at play here.

The State of Global Health Commodity Procurement: Moving from Data Points to the Bigger Picture

“Better data drive better decisions” is a truism that researchers everywhere are all too familiar with. Increasing the availability, usability, and relevance of data is key to tracking performance and informing smarter, more efficient policies—but too often the data we need simply aren’t available, at least not in a useful format. Recently, we’ve been exploring the availability of data (or lack thereof) related to global health commodity markets in the context of CGD’s working group on the Future of Global Health Procurement. To ground the working group’s recommendations, we’re trying to understand the current state of health commodity procurement in low- and middle-income countries (LMICs)—specifically which commodities are procured, by whom, how, and at what price.

Pages

Tags

Experts